Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Clinical trial NCT02294786 · TERMINATED
Trial details
- NCT number
- NCT02294786
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2017-10-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.